Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A WIMSical approach to decoding DNA methylation in myeloid leukemia
    Journal Article

    Guryanova, O. A.; Levine, R. L.
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E.; Tallman, M.; Pollyea, D. A.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; Levine, R. L.; Agresta, S.; Schenkein, D.; Yang, H.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Development and validation of a clinical next generation sequencing-based assay for hematologic malignancies
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; He, J.; Wang, K.; Knapp, K. M.; Brennan, K. W.; Donahue, A. L.; Young, L. E.; Young, G.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • How deregulation of histone methyltransferases drive malignant transformation of B-cells
    Meeting Abstract

    Béguelin, W.; Teater, M.; Popovic, R.; Jiang, Y. W.; Cerchietti, L.; Shaknovich, R.; Gascoyne, R.; Levine, R.; Abdel-Wahab, O.; Licht, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia
    Meeting Abstract

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Chen, C.; Rapaport, F.; Kishtagari, A.; Ahn, J.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Meeting Abstract

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z. X.; Tallman, M. S.; Patel, J. P.; Gonen, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo
    Meeting Abstract

    Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Mutation profiling of therapy-related myeloid neoplasms using next-generation sequencing demonstrates distinct profiles from de novo disease
    Meeting Abstract

    Shih, A. H.; Rapaport, F.; Chung, S. S.; Dolezal, E. K.; Hobson, S.; Amato, M. K.; Park, C. Y.; Sekeres, M. A.; van den Brink, M. R. M.; Nimer, S.; more...
    Blood (2014)

    Fulltext@MSK | Save